EUVIMEDEUVIMED entdecken
Crossref

Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway

Aihua Jiang, Lin Liu, Jianping Wang, Yinglan Liu, Shanshan Deng, Tao Jiang

Cardiovascular Toxicology · 2024

DOI: 10.1007/s12012-024-09863-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2024. Verfasst von Aihua Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Zhengxiang Dist…. Hauptthemen laut MEDLINE: ADAM10 Protein, Signal Transduction, Muscle, Smooth, Vascular, Cell Movement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular lesions frequently arise as complication in patients diagnosed with diabetes mellitus (DM). Presently, percutaneous coronary intervention (PCI) and antithrombotic therapy serve as primary treatments. However, in-stent restenosis persists as a challenging clinical issue following PCI, lacking sustained and effective treatment. Linarin (LN) exhibits diverse pharmacological activities and is regarded as a potential drug for treating various diseases, including DM. But its specific role in restenosis after vascular injury in DM patients remains unclear. A rat model of diabetes-related restenosis was established to evaluate the role of LN on neointimal hyperplasia. Vascular smooth muscle cells (VSMCs) stimulated by high glucose (HG, 30 mM) underwent LN treatment. Additionally, an overexpression plasmid of A disintegrin and metalloproteinases (ADAM10) was constructed to transfect VSMCs. We employed CCK-8, Brdu, wound-healing scratch, and transwell migration assays to evaluate the proliferation and migration of VSMCs. Furthermore, western blot and immunofluorescence assays were utilized to investigate the expressions of ADAM10 and the downstream Notch signaling pathway in vivo and in vitro models. LN notably alleviated intimal hyperplasia after vascular injury in DM rats and reduced the protein expression of ADAM10, alongside its downstream Notch1 signaling pathway-related proteins (Notch1, NICD and Hes1) in rat carotid artery tissues. LN effectively suppressed the proliferation and migration of VSMCs induced by HG, downregulating the protein expression of ADAM10, Notch1, NICD and Hes1. Moreover, our findings indicated that ADAM10 overexpression significantly reversed LN's effects on proliferation, migration, and the expression of Notch1 signaling pathway-related proteins in HG-treated VSMCs. LN demonstrates potential therapeutic efficacy in addressing restenosis after diabetic-related vascular injury, with the ADAM10 mediated Notch signaling pathway playing a pivotal role.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM10 ProteinSignal TransductionMuscle, Smooth, VascularCell MovementMyocytes, Smooth MuscleCell ProliferationRats, Sprague-DawleyNeointimaMembrane ProteinsAmyloid Precursor Protein SecretasesCarotid Artery InjuriesDiabetes Mellitus, ExperimentalAnimalsMaleCells, CulturedDiabetes Mellitus, Type 2HyperplasiaReceptors, NotchReceptor, Notch1Transcription Factor HES-1Disease Models, AnimalRatsCoronary Restenosis

Stichwörter der Autor:innen

ADAM10LinarinNotch signaling pathwayRestenosis after vascular injuryType II diabetes mellitus

Substanzen

ADAM10 ProteinMembrane ProteinsAmyloid Precursor Protein SecretasesReceptors, NotchReceptor, Notch1Transcription Factor HES-1ADAM10 protein, ratNotch1 protein, rat

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Zhengxiang District, Hengyang, 421001, Hunan Province, China.
  • Department of Gastroenterology, Hengyang Central Hospital, Hengyang, 421001, China.
  • Department of Endocrinology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, No. 35 Jiefang Road, Zhengxiang District, Hengyang, 421001, Hunan Province, China. qq505142506@163.com.

Zitieren

APA

Jiang, A., Liu, L., Wang, J., Liu, Y., Deng, S., & Jiang, T. (2024). Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09863-4

Vancouver

Jiang A, Liu L, Wang J, Liu Y, Deng S, Jiang T. Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway. Cardiovascular Toxicology. 2024. doi:10.1007/s12012-024-09863-4

BibTeX
@article{Jiang2024,
  author = {Jiang, Aihua and Liu, Lin and Wang, Jianping and Liu, Yinglan and Deng, Shanshan and Jiang, Tao},
  title = {Linarin Ameliorates Restenosis After Vascular Injury in Type 2 Diabetes Mellitus via Regulating ADAM10-Mediated Notch Signaling Pathway},
  journal = {Cardiovascular Toxicology},
  year = {2024},
  doi = {10.1007/s12012-024-09863-4}
}
Kostenlos starten →